Clinical Trial Update: Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for an Ebola vaccine (V920-001) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• V920-001

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Ebola Virus | Phase 1 | Status: COMPLETED | Results posted: 2019-10-23